Scarica l'app Stockscreener
2.02
5.61%
-0.12
Milestone Pharmaceuticals Inc Borsa (MIST) Ultime notizie
Shuttle Pharma Reaches Milestone in Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma - The Manila Times
Shuttle Pharma Reaches Milestone in Patient Enrollment for - GlobeNewswire
Dogwood Therapeutics Poised For Data Milestone In Chemotherapy-Induced Neuropathic Pain In 2H 2025 - RTTNews
This Data Shows Just How Strong Milestone Pharmaceuticals Inc (NASDAQ: MIST) Stock Is - Stocks Register
NRx Pharmaceuticals Advances Towards FDA Approval with Key Stability Milestone for NRX-100 - MSN
Acadia Pharmaceuticals: Billion-Dollar Milestone and Global Expansion in 2025 - Yahoo Finance
Acadia Pharma Targets $1B Sales Milestone in 2025, Expands DAYBUE to European Market - StockTitan
C4 Therapeutics Announces 2025 Milestones Across Clinical Portfolio of Degrader Medicines Pursuing Targets of High Unmet Need in Oncology - The Manila Times
Xenon Pharmaceuticals Sets Sights on Key 2025 Milestones - TipRanks
Rakovina Therapeutics Announces Key Milestone in Cancer Drug Innovation in Collaboration with Variational AI - GlobeNewswire
CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2025 Milestones - Yahoo Finance
MimiVax and UI Pharmaceuticals Achieve Milestone in SurVaxM Production for Glioblastoma Treatment - BioSpace
Goa to Lead in Pharma Growth as Zlata Pharma Sets Industry Milestones - Yahoo Finance
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Milestone Pharmaceuticals Awards 113,000 Stock Options to New Key Employees - StockTitan
Milestone Pharmaceuticals (NASDAQ:MIST) Shares Down 8.1%Time to Sell? - MarketBeat
Milestone Pharmaceuticals (NASDAQ:MIST) Trading Down 8.1% – Time to Sell? - Defense World
Milestone Pharmaceuticals Inc (NASDAQ: MIST): An Enticing Stock To Watch - Stocks Register
Hemogenyx Pharmaceuticals achieves new milestone with patient recruitment for first clinical trial - Proactive Investors USA
MIST Stock Hits 52-Week High at $2.42 Amid Positive Momentum - Investing.com Australia
Tonix Pharmaceuticals achieves key milestone with FDA review timeline for innovative Fibromyalgia treatment - Proactive Investors USA
Ionis gets a milestone approval; Another top FDA official to step down - BioPharma Dive
MIRA Pharmaceuticals Submits IND for Ketamir-2 to FDA, Marking a Significant Milestone in the Company's Pipeline Development - AccessWire
Tonix Pharma’s TNX-102 SL Nears FDA Approval Milestone - TipRanks
Pieris Pharmaceuticals Announces $5 Million Milestone from Seagen for Initiation of Phase 1 Trial of Cd228 X 4-1Bb Bispecific Molecule (Mabcalin Sgn-Bb228 (Prs-346) - Marketscreener.com
Novartis Ag ADR (NVS-N) QuotePress Release - The Globe and Mail
Novartis and the pan-Canadian Pharmaceutical Alliance achieve milestone agreement for PLUVICTO™ - Barchart
Jazz Pharmaceuticals Marks International Volunteers Day with Corporate Impact Milestone - StockTitan
Medigene Receives Milestone Payment from Regeneron Pharmaceuticals, Inc. - Marketscreener.com
Candel therapeutics chief medical officer sells $63,482 in stock - Investing.com
Sudden Hearing Loss Study Reaches Milestone: AudioCure Pharma Enrolls More Than Half of the Patients in AC102 Study - Yahoo Finance
Milestone Pharmaceuticals to Present at the Piper Sandler 36th Annual Healthcare Conference - The Manila Times
After Golden Cross, Milestone Pharmaceuticals (MIST)'s Technical Outlook is Bright - MSN
Milestone Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Rare milestone for Canadian biotech as Zymeworks-developed drug gets FDA approval - The Globe and Mail
FDA Greenlights Jazz Pharma's Cancer Drug, A Milestone For Zymework - Benzinga
Update on Clinical MilestoneCytoMed Therapeutics Announces First Patient Dosed in its First-in-Human Phase I Clinical Trial of Allogeneic CAR-Gamma Delta T Cell Therapy in Patients with Advanced Solid Tumours or Haematological Malignancies - Yahoo Finance
Seres Therapeutics Q3 2024 Earnings Preview - MSN
NeuroBo Pharmaceuticals Announces Strategic Realignment Ahead of Important Clinical Milestones with Name Change to MetaViaReflecting the Company's Focus on Cardiometabolic Diseases - Yahoo Finance
Milestone Pharmaceuticals Inc. (MIST) Quarterly 10-Q Report - Quartz
Milestone Pharmaceuticals: Q3 Earnings Snapshot - Darien Times
Gyre Therapeutics Revenue Falls 20% as Phase 3 Trial Milestone Nears Critical Data | GYRE Stock News - StockTitan
Milestone Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Regulatory and Corporate Update - The Manila Times
Milestone Pharma Trims Losses 38% as CARDAMYST Shows Strong Phase 3 Results in China | MIST Stock News - StockTitan
BridgeBio's Acoramidis Nears FDA Approval; $500M Milestone Payment Awaits | BBIO Stock News - StockTitan
Armata Pharmaceuticals Hits Key Milestone in Bacteriophage Therapy Trial, Eyes 2025 Data | ARMP Stock News - StockTitan
Arcturus Therapeutics Hits $25M Milestone, Narrows Losses Despite Revenue Dip | ARCT Stock News - StockTitan
Royalty Pharma Reports Third Quarter 2024 Results - ForexTV.com
0.86%
7.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):